These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32883322)

  • 1. Efficacy and safety of Jia Wei Bushen Yiqi formulas as an adjunct therapy to systemic glucocorticoids on acute exacerbation of COPD: study protocol for a randomized, double-blinded, multi-center, placebo-controlled clinical trial.
    Kong Q; Mo S; Wang W; Tang Z; Wei Y; Du Y; Liu B; Kong L; Lv Y; Dong J
    Trials; 2020 Sep; 21(1):760. PubMed ID: 32883322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of modified Bushen Yiqi formulas (MBYF) as an add-on to formoterol and budesonide in the management of COPD: study protocol for a multicentre, double-blind, placebo-controlled, parallel-group, randomized clinical trial: FB-MBYF Trial.
    Kong Q; Cao Y; Gao Z; Sun J; Zhang H; Du Y; Lv Y; Zhou S; Tang Z; Liu B; Dong J
    Trials; 2022 Feb; 23(1):143. PubMed ID: 35164853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of Xuebijing injection and its influence on immunomodulation in acute exacerbations of chronic obstructive pulmonary disease: study protocol for a randomized controlled trial.
    Xie S; Yan P; Yao C; Yan X; Huo Y; Zhang J; Liu S; Feng Z; Shang H; Xie L
    Trials; 2019 Feb; 20(1):136. PubMed ID: 30777117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.
    Leuppi JD; Schuetz P; Bingisser R; Bodmer M; Briel M; Drescher T; Duerring U; Henzen C; Leibbrandt Y; Maier S; Miedinger D; Müller B; Scherr A; Schindler C; Stoeckli R; Viatte S; von Garnier C; Tamm M; Rutishauser J
    JAMA; 2013 Jun; 309(21):2223-31. PubMed ID: 23695200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial for prevention of acute exacerbation of stable chronic obstructive pulmonary disease with acupoint application of traditional Chinese medicine: Study protocol clinical trial (SPIRIT Compliant).
    Zhang C; Yang H; Gan W; Chen J; Yang Y; Xiao W; Long K; Chen K; Huang Q; Gao P
    Medicine (Baltimore); 2020 Mar; 99(10):e19396. PubMed ID: 32150085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of YuPingFeng granules on clinical symptoms of stable COPD: study protocol for a multicenter, double-blind, and randomized controlled trial.
    Chen R; Zhan Y; Lin Z; Wu X; Zhou J; Yang Z; Zheng J
    BMC Complement Med Ther; 2024 Jan; 24(1):25. PubMed ID: 38191338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of Qingfei Huatan formula in the treatment of acute exacerbation of chronic obstructive pulmonary disease: A multi-centre, randomised, double-blind, placebo-controlled trial.
    Zhu HZ; Li CY; Liu LJ; Tong JB; Lan ZH; Tian SG; Li Q; Tong XL; Wu JF; Zhu ZG; Li SY; Li JS
    J Integr Med; 2024 Sep; 22(5):561-569. PubMed ID: 39060126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sequential treatment with syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and "AECOPD Risk-Window": study protocol for a randomized placebo-controlled trial.
    Haifeng W; Jiansheng L; Suyun L; Xueqing Y; Hailong Z; Zhiwan W; Qiyi W; Pankui Z; Zhongchao W; Fenglei L; Haihong Y
    Trials; 2012 Apr; 13():40. PubMed ID: 22520863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional Chinese medicine may reduce the dosage of systemic glucocorticoids in required patients with acute exacerbation of chronic obstructive pulmonary disease: Study protocol for a randomized placebo-controlled trial.
    Zhao K; Chen K; Huang Q; Gao P; Zhang C; Yang H; Gan W; Xiao W; Sun Z; Xie X; Long K; Zhang S; Chen J
    Medicine (Baltimore); 2020 May; 99(18):e20035. PubMed ID: 32358383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency and Safety of Baofei Granules in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial.
    Sun Y; Chen X; Zhang L; Yuan WA; Chen Q; Zhang YB; Liu LJ; Zhang W; Sun M
    Drug Des Devel Ther; 2022; 16():4251-4267. PubMed ID: 36540716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial).
    Urwyler P; Boesing M; Abig K; Cattaneo M; Dieterle T; Zeller A; Bachler H; Markun S; Senn O; Merlo C; Essig S; Ullmer E; Rutishauser J; Schuurmans MM; Leuppi JD
    Trials; 2019 Dec; 20(1):727. PubMed ID: 31842993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the Chinese herbal formula San-Huang Gu-Ben Zhi-Ke treatment on stable chronic obstructive pulmonary disease: study protocol of a randomized, double-blind, placebo-controlled trial.
    Zu Y; Li D; Lei X; Zhang H
    Trials; 2019 Nov; 20(1):647. PubMed ID: 31775843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose N-acetylcysteine for long-term, regular treatment of early-stage chronic obstructive pulmonary disease (GOLD I-II): study protocol for a multicenter, double-blinded, parallel-group, randomized controlled trial in China.
    Tian H; Zhou Y; Tang L; Wu F; Deng Z; Lin B; Huang P; Wei S; Zhao D; Zheng J; Zhong N; Ran P
    Trials; 2020 Sep; 21(1):780. PubMed ID: 32917271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study.
    Ma J; Zheng J; Zhong N; Bai C; Wang H; Du J; Li F; Chen Y; Shi Z; Li X; Chen P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3107-3114. PubMed ID: 30323581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease - the "REDUCE" trial.
    Schuetz P; Leuppi JD; Tamm M; Briel M; Bingisser R; Dürring U; Müller B; Schindler C; Viatte S; Rutishauser J
    Swiss Med Wkly; 2010; 140():w13109. PubMed ID: 21136333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sequential treatment with TCM syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and AECOPD risk window.
    Jiansheng L; Haifeng W; Suyun L; Hailong Z; Xueqing Y; Xiaoyun Z; Fengsen L; Xianmei Z; Zikai S; Yimin M; Lijun M; Yijie Z; Guojun Z; Bingxiang T
    Complement Ther Med; 2016 Dec; 29():109-115. PubMed ID: 27912934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of Chinese herbal medicine Shen-Qi Hua-Yu formula in patients with diabetic lower extremity artery disease: Study protocol of a multi-center, randomized, double-blind, placebo-controlled trial.
    Leng Y; Gao H; Fu X; Xie H; Hu Z; Zhu J; Liu X; Zhou X; Xie Z; Xie C
    Medicine (Baltimore); 2020 Jan; 99(3):e18713. PubMed ID: 32011447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Chinese Herbal Medicine on Acute Exacerbations of COPD: A Randomized, Placebo-Controlled Study.
    Li J; Zhang H; Ruan H; Si Y; Sun Z; Liu H; Feng J; Wang Y; Li L; Bai L; Sun H
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2901-2912. PubMed ID: 33209019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Xin Jia Xuan Bai Cheng Qi Decoction in treating acute exacerbation of chronic obstructive pulmonary disease: study protocol for a multicentre, randomised, controlled trial.
    Jin J; Zhang H; Li D; Jing Y; Sun Z; Feng J; Zhang H; Zhang Y; Cui T; Lei X; Zhang J; Cheng Q; Li E
    BMJ Open; 2019 Nov; 9(11):e030249. PubMed ID: 31784433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.